Our laboratories

We have the expertise to conduct studies on small molecules, large molecules, and antibody-drug conjugates, utilizing a range of analytical platforms : LC-MS/MS, immunoassays, and cell-based assays.

Custom immunoassays, ADA/NAb testing, biomarkers & PK/PD: agile, GLP-compliant bioanalysis tailored to the development of biologics.

In-vivo studies to identify the most promising drug candidates based on bioavailability and PK profiles, prior to initiating GLP-compliant pre-clinical studies. Radiolabelled or cold test item.

We offer GLP-compliant biomarker services from development to validation, providing reliable data with advanced technologies and expertise to support every phase of your projects.

Topical product development, IVRT/IVPT, skin PK, bioequivalence & radiolabel studies under GLP/OECD/SCCS – for pharma, cosmetics & dermal product bioanalysis.

Development, Transfer, Validation & Sample Analysis: mAbs, ADCs, fusion proteins, DARPS, bispecifics, enzymes, oligos, PEG products, viral vectors, vaccines, gene therapies, biosimilars, CAR-T

Extensive ADA and NAb method development, validation, and analysis using diverse platforms to ensure drug tolerance and high sensitivity for even the most difficult assays.

We tailor biomarker assay development, validation, and analysis to your needs—using kits, de novo methods, or multiplex solutions to meet regulatory standards.

Support a wide array of cell-based assays for the evaluation of NAbs to immunophenotyping, and cell activation utilizing flow cytometry, cell culture, ELISpot, and other methodologies.

GLP and GCLP assay development, validation and sample analysis for qPCR assays in support of biodistribution, vector shedding, and PK endpoints.

Expertise in PK and ADA assays for biosimilars, with access to select originator assays for starting points for PK and ADA method development.

Our scientists and medical experts provide strategical and methodological advice based in order to help you plan coherent and robust studies, mitigate risk and optimize resources.

Our regulatory experts continuously monitor country-specific regulatory and ethics restrictions, requirements and liaise with all relevant stakeholders so that submissions are always fully compliant.

Strategically located in Grenoble, France, our facilities are exclusively dedicated to conducting clinical trials in healthy volunteers and in ambulatory patients with all needed medical equipment.

Whether you intend to conduct a single-country single-site or an international multi-centre study, we can take responsibility for every aspect of it.

Translate your clinical practice into data-driven conclusions

With 35 years of experience in early-phase clinical trial, our medical team's expertise is a key advantage to the sucess of your project, wheter in Europe or abroad.

Custom development, validation and optimization of qPCR and genotyping assays; multiple-target, dual gene assays designed to eliminate risk of false negatives/under-quantified viral loads.

Broad based experience with complex immunoassays using multiple platforms and assay types, PBMCs with both infectious disease and cancer vaccine antigenic stimulation, and cell-based assay/analysis.

Plate-based, Cell-based Testing (ADA/NAb), Clinical Trials (FIH – Ph3) Bridging, Competitive, Acid Dissociation, Traditional, dsDNA, Gene & Cell Therapies, TCID50, Plaque, Live-cell, ELISpot, CMI

Custom qPCR & ddPCR, RCR/RCL PCR safety testing, Next generation sequencing (NGS) & comprehensive genomic profiling w/biostatistics, nanoString, Whole genome (WGS), Whole exome (WES), RNASeq

A comprehensive technology portfolio providing custom assay design, validation, and analysis for PCR, ddPCR, Sanger, NGS (WGS, WES, RNASeq, somatic testing, nanoString, flow cytometry & more.

ADA, NAb, viral shedding, biodistribution, qPCR, ddPCR, ELISA, ELISpot, flow cytometry, vaccines, CAR T, CRS, MSD, whole exome, RNA, Luminex, NGS, immunoassay, gene expression, ligand-binding assays